565 related articles for article (PubMed ID: 21752886)
1. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
Feelders RA; Hofland LJ; de Herder WW
Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
[TBL] [Abstract][Full Text] [Related]
4. A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
Valassi E; Crespo I; Gich I; Rodríguez J; Webb SM
Clin Endocrinol (Oxf); 2012 Nov; 77(5):735-42. PubMed ID: 22533782
[TBL] [Abstract][Full Text] [Related]
5. Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
Corcuff JB; Young J; Masquefa-Giraud P; Chanson P; Baudin E; Tabarin A
Eur J Endocrinol; 2015 Apr; 172(4):473-81. PubMed ID: 25624013
[TBL] [Abstract][Full Text] [Related]
6. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
7. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
Braun LT; Reincke M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
[TBL] [Abstract][Full Text] [Related]
8. Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
Claps M; Cerri S; Grisanti S; Lazzari B; Ferrari V; Roca E; Perotti P; Terzolo M; Sigala S; Berruti A
Endocrine; 2018 Jul; 61(1):169-172. PubMed ID: 29019062
[No Abstract] [Full Text] [Related]
9. Use of ketoconazole in the treatment of Cushing's syndrome.
Loli P; Berselli ME; Tagliaferri M
J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
[TBL] [Abstract][Full Text] [Related]
10. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
11. [Medical treatment for Cushing's syndrome].
Nishikawa T; Saito J; Omura M
Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
[TBL] [Abstract][Full Text] [Related]
12. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
van den Bosch OF; Stades AM; Zelissen PM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
[TBL] [Abstract][Full Text] [Related]
13. Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia.
Debillon E; Velayoudom-Cephise FL; Salenave S; Caron P; Chaffanjon P; Wagner T; Massoutier M; Lambert B; Benoit M; Young J; Tabarin A; Chabre O
J Clin Endocrinol Metab; 2015 Dec; 100(12):4417-24. PubMed ID: 26451908
[TBL] [Abstract][Full Text] [Related]
14. The medical management of Cushing's syndrome during pregnancy.
Lim WH; Torpy DJ; Jeffries WS
Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):1-6. PubMed ID: 23305861
[TBL] [Abstract][Full Text] [Related]
15. Management of diabetes mellitus in Cushing's syndrome.
Munir A; Newell-Price J
Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
[TBL] [Abstract][Full Text] [Related]
16. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Engelhardt D; Weber MM
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
[TBL] [Abstract][Full Text] [Related]
17. A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.
Valassi E; Aulinas A; Glad CA; Johannsson G; Ragnarsson O; Webb SM
Clin Endocrinol (Oxf); 2017 Nov; 87(5):433-439. PubMed ID: 28665508
[TBL] [Abstract][Full Text] [Related]
18. Prolonged treatment of Cushing's disease by ketoconazole.
Sonino N; Boscaro M; Merola G; Mantero F
J Clin Endocrinol Metab; 1985 Oct; 61(4):718-22. PubMed ID: 4031015
[TBL] [Abstract][Full Text] [Related]
19. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
Thorén M; Adamson U; Sjöberg HE
Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
[TBL] [Abstract][Full Text] [Related]
20. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
